Targeting inflammation in metabolic syndrome

Welty, Francine K., Alfaddagh, Abdulhamied, Elajami, Tarec K.·2016·Translational Research
DOI 10.1016/j.trsl.2015.06.017

Cites (262)

Items 201–262 of 262

  1. Differential effects of regulatory T cells on the initiation and regression of atherosclerosis
    Amanda C. Foks, Vanessa Frodermann, Mariëtte ter Borg, Kim L. L. Habets, Ilze Bot, Ying Zhao, Miranda Van Eck, Th.J.C. van Berkel, Johan Kuiper, Gijs H.M. van Puijvelde · 2011 · Atherosclerosis
  2. A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels
    Clemens von Schacky · 2006 · Vascular Health and Risk Management
  3. Endotoxin, TLR4 Signaling and Vascular Inflammation: Potential Therapeutic Targets in Cardiovascular Disease
    Lynn L. Stoll, Gerene M. Denning, Neal L. Weintraub · 2006 · Current Pharmaceutical Design
  4. Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat
    Xiangbo Ruan, Zhenghu Li, Yixuan Zhang, Ling Yang, Yi Pan, Zhenzhen Wang, Gen‐Sheng Feng, Yan Chen · 2010 · Journal of Cellular and Molecular Medicine
  5. The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance
    Ersilia Cipolletta, Alfonso Campanile, Gaetano Santulli, Emma Sanzari, Dario Leosco, Pietro Campiglia, Bruno Trimarco, Guido Iaccarino · 2009 · Cardiovascular Research
  6. Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo
    Mohan R. K. Dasu, Andrea C. Riosvelasco, Ishwarlal Jialal · 2008 · Atherosclerosis
  7. Increased Saturated Fatty Acids in Obesity Alter Resolution of Inflammation in Part by Stimulating Prostaglandin Production
    Jason L. Hellmann, Michael J. Zhang, Yunan Tang, Madhavi J. Rane, Aruni Bhatnagar, Matthew R. Spite · 2013 · The Journal of Immunology
  8. Antihypertensive drugs and glucose metabolism
    Christos V. Rizos · 2014 · World Journal of Cardiology
  9. Adaptive T cell immune responses and atherogenesis
    Soraya Taleb, Alain Tedgui, Ziad Mallat · 2010 · Current Opinion in Pharmacology
  10. A Docking Receptor for HDL Cholesterol Esters
    Daniel Howard Steinberg · 1996 · Science
  11. Effect of IL‐4 and IL‐13 on collagen production in cultured LI90 human hepatic stellate cells
    Rie Sugimoto, Munechika Enjoji, Makoto Nakamuta, Satoshi Ohta, Motoyuki Kohjima, Marie Fukushima, Masami Kuniyoshi, Eiichiro Arimura, Shusuke Morizono, Kazuhiro Kotoh et al. · 2005 · Liver International
  12. The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population
    Tammy C. Lee, Priscilla Ivester, Austin G. Hester, Susan Sergeant, L. Douglas Case, Timothy M. Morgan, Ethel O. Kouba, Floyd H. Chilton · 2014 · Lipids in Health and Disease
  13. Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: An integrated backscatter intravascular ultrasound study
    Tetsuya Amano, Tatsuaki Matsubara, Tadayuki Uetani, Masataka Kato, Bunichi Kato, Tomohiro Yoshida, Ken Harada, Soichiro Kumagai, Ayako Kunimura, Yusaku Shinbo et al. · 2011 · Atherosclerosis
  14. Possible Role of Angiotensin-Converting Enzyme 2 and Activation of Angiotensin II Type 2 Receptor by Angiotensin-(1–7) in Improvement of Vascular Remodeling by Angiotensin II Type 1 Receptor Blockade
    Kousei Ohshima, Masaki Mogi, Hirotomo Nakaoka et al. · 2013 · Hypertension
  15. G Protein-Coupled Receptor Kinase 2 Mediates Endothelin-1-Induced Insulin Resistance via the Inhibition of Both Gαq/11 and Insulin Receptor Substrate-1 Pathways in 3T3-L1 Adipocytes
    Isao Usui, Takeshi Imamura, Jennie L. Babendure, Hiroaki Satoh, Juu-Chin Lu, Christopher J. Hupfeld, Jerrold M. Olefsky · 2005 · Molecular Endocrinology
  16. Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts
    Andrew M. Cheng, Priya Handa, Sanshiro Tateya, Jay Schwartz, Chongren Tang, Poulami Mitra, John F. Oram, Alan Chait, Francis Kim · 2012 · PLoS ONE
  17. Orally Administered Eicosapentaenoic Acid Induces Rapid Regression of Atherosclerosis Via Modulating the Phenotype of Dendritic Cells in LDL Receptor-Deficient Mice
    Kenji Nakajima, Tomoya Yamashita, Tomoyuki Kita, Masafumi Takeda, Naoto Sasaki, Kazuyuki Kasahara, Masakazu Shinohara, Yoshiyuki Rikitake, Tatsuro Ishida, Mitsuhiro Yokoyama et al. · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
  18. Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells
    Tzu-Ming Wang, Chun‐Jung Chen, Tzong‐Shyuan Lee, Han-Yi Chao, Wen-Huey Wu, Shu‐Chen Hsieh, Huey-Herng Sheu, An‐Na Chiang · 2010 · The Journal of Nutritional Biochemistry
  19. Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol
    Vikman, Jenny, Jimenez‐Feltström, Javier, Nyman, Per, Eliasson, Lena · 2009 · The FASEB Journal
  20. Assessing inflammatory status in cardiovascular disease
    Dimitris Tousoulis, C. Antoniades, Christodoulos Stefanadis · 2007 · Heart
  21. Insulin sensitivity and the effects of insulin on renal sodium handling and pressor systems in essential hypertensive patients.
    Kazuaki Shimamoto, Akifumi Hirata, Masatada Fukuoka, Katsuhiro Higashiura, Y Miyazaki, MAMORU SHIIKI, A Masuda, Motoya Nakagawa, Osamu Iimura · 1994 · Hypertension
  22. Omega-3 Fatty Acids Ameliorate Atherosclerosis by Favorably Altering Monocyte Subsets and Limiting Monocyte Recruitment to Aortic Lesions
    Amanda L. Brown, Xuewei Zhu, Shunxing Rong, Swapnil V. Shewale, Jeongmin Seo, Elena Y. Boudyguina, Abraham K. Gebre, Martha A. Alexander‐Miller, John S. Parks · 2012 · Arteriosclerosis Thrombosis and Vascular Biology
  23. Peroxisome proliferator-activated receptor α controls cellular cholesterol trafficking in macrophages
    Giulia Chinetti, Elena Rigamonti, L. Helin, Aino Mutka, Marco Lepore, Jean‐Charles Fruchart, Véronique Barthelemy-Clavey, Elina Ikonen, Sophie Lestavel, Bart Staels · 2005 · Journal of Lipid Research
  24. Role of Mitochondria in β-cell Function and Dysfunction
    Pierre Maechler, Ning Li, Marina Casimir, Laurène Vetterli, Francesca Frigerio, Thierry Brun · 2010 · Advances in experimental medicine and biology
  25. Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk—the PIOSTAT Study
    Thomas M. Forst, Andreas Pfützner, Georg Lübben, Matthias M. Weber, Nikolaus Marx, Efstrathios Karagiannis, Carsta Koehler, Werner Baurecht, Cloth Hohberg, Markolf Hanefeld E · 2007 · Metabolism
  26. Impaired Insulin Secretion in Four Tangier Disease Patients with ABCA1 Mutations
    Koseki, Masahiro, Matsuyama, Akifumi, Nakatani, Kazuhiro, Inagaki, Miwako, Nakaoka, Hajime, Kawase, Ryota, Yuasa-Kawase, Miyako, Tsubakio-Yamamoto, Kazumi, Masuda, Daisaku, C. Sandoval, Jose et al. · 2009 · Journal of Atherosclerosis and Thrombosis
  27. Induction of Cytosolic Phospholipase A2α Is Required for Adipose Neutrophil Infiltration and Hepatic Insulin Resistance Early in the Course of High-Fat Feeding
    Nurit Hadad, Olga Burgazliev, Vered Elgazar-Carmon, Yulia Solomonov, Stephan Wueest, Flurin Item, Daniel Konrad, Assaf Rudich, Rachel Lévy · 2013 · Diabetes
  28. Apolipoprotein A-I Increases Insulin Secretion and Production From Pancreatic β-Cells via a G-Protein-cAMP-PKA-FoxO1–Dependent Mechanism
    Blake J. Cochran, Radjesh J. Bisoendial, Liming Hou, Elias N. Glaros, Jérémie Rossy, Shane Ross Thomas, Philip J. Barter, K.-A. Rye · 2014 · Arteriosclerosis Thrombosis and Vascular Biology
  29. Apolipoprotein A-I Inhibits CD40 Proinflammatory Signaling via ATP-Binding Cassette Transporter A1-Mediated Modulation of Lipid Raft in Macrophages
    Kai Yin, Wujun Chen, Zhigang Zhou, Guojun Zhao, Yun-Chen Lv, Xin-Pin Ouyang, Xiao-Hua Yu, Yuchang Fu, Zhisheng Jiang, Chao‐Ke Tang · 2012 · Journal of Atherosclerosis and Thrombosis
  30. Combined Therapy of Dietary Fish Oil and Stearoyl-CoA Desaturase 1 Inhibition Prevents the Metabolic Syndrome and Atherosclerosis
    Jonathan Mark Brown, Soonkyu Chung, Janet K. Sawyer, Chiara Degirolamo, Heather M. Alger, Tam M. Nguyen, Xuewei Zhu, MyNgan Duong, Amanda L. Brown, Caleb C. Lord et al. · 2009 · Arteriosclerosis Thrombosis and Vascular Biology
  31. The influence of EPA and DHA on markers of inflammation in 3T3-L1 cells at different stages of cellular maturation
    Adam Prostek, Małgorzata Gajewska, Dariusz Kamola, Bozena Bałasińska · 2014 · Lipids in Health and Disease
  32. Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.
    Ephraim Sehayek, U Lewin-Velvert, Tova Chajek‐Shaul, S Eisenberg · 1991 · Journal of Clinical Investigation
  33. Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy
    Carlos Arauz-Pacheco, Luis C. Ramirez, Juan M. Rios, Philip Raskin · 1990 · The American Journal of Medicine
  34. Diet and Metabolic Syndrome
    Djousse, L., Padilla, H., Nelson, T.L., Gaziano, J.M., Mukamal, K.J. · 2010 · Endocrine, Metabolic & Immune Disorders - Drug Targets
  35. The role of superoxide radical in TNF-alpha induced NF-kappaB activation.
    Sheng Wang, Stephen S. Leonard, Vincent Castranova, Val Vallyathan, Xianglin Shi · 1999 · PubMed
  36. Triglyceride-Rich Lipoprotein-Associated Apolipoprotein C-III Production Is Stimulated by Plasma Free Fatty Acids in Humans
    Mirjana Pavlic, René Valéro, Hélène Duez, Changting Xiao, Linda Szeto, Bruce W. Patterson, Gary F. Lewis · 2008 · Arteriosclerosis Thrombosis and Vascular Biology
  37. Simvastatin (40 mg/day), Adiponectin Levels, and Insulin Sensitivity in Subjects With the Metabolic Syndrome
    Sridevi Devaraj, David Siegel, Ishwarlal Jialal · 2007 · The American Journal of Cardiology
  38. New Therapeutic Target for Metabolic Syndrome: PPAR.DELTA.
    Sadao Takahashi, Toshiya Tanaka, Juro Sakai · 2007 · Endocrine Journal
  39. Differential Impact of Atorvastatin vs Pravastatin on Progressive Insulin Resistance and Left Ventricular Diastolic Dysfunction in a Rat Model of Type II Diabetes
    Yan Chen, Koji Ohmori, Mizuki Mizukawa, Junji Yoshida, Yu Zeng, Ling Zhang, Kaori Shinomiya, Hiroaki Kosaka, Masakazu Kohno · 2006 · Circulation Journal
  40. Caveolae: A regulatory platform for nutritional modulation of inflammatory diseases
    Joseph D. Layne, Zuzana Májková, Eric J. Smart, Michal J. Toborek, Bernhard Hennig · 2011 · The Journal of Nutritional Biochemistry
  41. Plasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy.
    Orhan Ateş, Habip Bilen, Sadullah Keleş, Hamit Hakan, Mevlüt Sait Keleş, Kenan Yıldırım, Osman Öndaş, Can Lokman Pinar, Mustafa Civelekler, Orhan Baykal · 2013 · Europe PMC (PubMed Central)
  42. Telmisartan as a metabolic sartan: The first meta-analysis of randomized controlled trials in metabolic syndrome
    Hisato Takagi, Masao Niwa, Yusuke Mizuno, Shin-nosuke Goto, Takuya Umemoto · 2013 · Journal of the American Society of Hypertension
  43. Transcriptional inhibition of the human insulin receptor gene by aldosterone.
    C. Calle, J. Campión, M. García-Arencibia, B. Maestro, N. Dȧvila · 2003 · Journal of Steroid Biochemistry and Molecular Biology
  44. CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice
    Lingli Dong, Ken Watanabe, Mari Nogami Itoh, C.-R. Huan, Xiaopeng Tong, Tomomi Nakamura, M. Miki, Haruka Kawanami Iwao, Akio Nakajima, Tomoyuki Sakai et al. · 2012 · International Immunology
  45. Hypertriglyceridemia: A Review Beyond Low-Density Lipoprotein
    Richard J. Rapp · 2002 · Cardiology in Review
  46. Metabolic remodelling in obesity and type 2 diabetes: pathological or protective mechanisms in response to nutrient excess?
    Timothy Connor, Sheree D. Martin, Kirsten F. Howlett, Sean L. McGee · 2014 · Clinical and Experimental Pharmacology and Physiology
  47. The role of the cholesteryl ester transfer protein in lipoprotein metabolism
    Theresa L. Swenson · 1991 · Diabetes/Metabolism Reviews
  48. Pathogenesis and Management of the Diabetogenic Effect of Statins: a Role for Adiponectin and Coenzyme Q10?
    Dick C. Chan, Jing Pang, Gerald Francis Watts · 2014 · Current Atherosclerosis Reports
  49. Can correction of sub-optimal coenzyme Q status improve beta-cell function in type II diabetics?
    M. McCarty · 1999 · Medical Hypotheses
  50. T Cell Costimulatory and Coinhibitory Pathways in Vascular Inflammatory Diseases
    Andrew H. Lichtman · 2012 · Frontiers in Physiology
  51. The Complex Metabolic Mechanisms Relating Obesity to Hypertriglyceridemia
    Robert H. Eckel · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
  52. Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension
    Akira Sato, S Fukuda · 2009 · Journal of Human Hypertension
  53. PPARδ agonists and metabolic diseases
    Kihwa Kang, Ben Hatano, Chih‐Hao Lee · 2007 · Current Atherosclerosis Reports
  54. Dietary n-3 LCPUFA from fish oil but not α-linolenic acid-derived LCPUFA confers atheroprotection in mice
    Chiara Degirolamo, Kathryn L. Kelley, Martha D. Wilson, Lawrence L. Rudel · 2010 · Journal of Lipid Research
  55. Vascular relaxation to omega-3 fatty acids: Comparison to sodium nitroprusside, nitroglycerin, papaverine, and D600
    Mary B. Engler · 1992 · Cardiovascular Drugs and Therapy
  56. Nuclear SREBP-1a causes loss of pancreatic β-cells and impaired insulin secretion
    Yuko Iwasaki, Hitoshi O. IWASAKI, Shigeru Yatoh, Mayumi Ishikawa, Toyonori Kato, Takashi Matsuzaka, Yoshimi Nakagawa, Naoya Yahagi, Kazuto Kobayashi, Akimitsu Takahashi et al. · 2008 · Biochemical and Biophysical Research Communications
  57. Heat shock transcription factor δ32 is targeted for degradation via an ubiquitin-like protein ThiS in Escherichia coli
    Xibing Xu, Yulong Niu, Ke Liang, Jianmei Wang, Xufeng Li, Yi Yang · 2015 · Biochemical and Biophysical Research Communications
  58. PPARα: its role in the human metabolic syndrome
    Salman Azhar, Glen Kelley · 2007 · Future Lipidology
  59. APOC3 Mutation, Serum Triglyceride Concentrations, and Coronary Heart Disease
    Michael Y. Tsai, José María Ordovás · 2009 · Clinical Chemistry
  60. T CELLS ARE ACTIVE PARTICIPANTS IN THE PROGRESSION OF ATHEROSCLEROTIC PLAQUES
    Felicia Antohe · 2011
  61. Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178
    Katsuyuki Nakajima, Junji Kobayashi · 2013 · Expert Opinion on Therapeutic Patents
  62. Omega-3 fatty acids: a novel resort against gastrointestinal injury.
    Gianluca Ianiro, Francesco Franceschi, Stefano Bibbò · 2014 · PubMed